Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ALNY | BIIB | ARGX | ||
Company | Alnylam Pharmaceuticals | Biogen Inc | Argenx Se ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 243.00 | 231.71 | 437.14 | ||
High | 250.11 | 233.17 | 444.49 | ||
Low | 242.07 | 225.10 | 429.27 | ||
Last | 247.61 | 228.82 | 435.49 | ||
Change | +4.29 | -2.95 | +1.27 | ||
% Change | +1.76% | -1.27% | +0.29% | ||
Volume | 1,579,300 | 860,200 | 287,000 | ||
20-Day Average Volume | 1,756,220 | 1,076,545 | 319,645 | ||
Previous Close | 243.32 | 231.77 | 434.22 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 185.83 | 228.56 | 403.07 | ||
20-Day Raw Stochastic | 95.02% | 50.23% | 75.95% | ||
20-Day Relative Strength | 84.75% | 53.41% | 63.48% | ||
Weighted Alpha | +17.81 | -13.83 | -1.21 | ||
Today's Opinion | 56% Buy | 8% Buy | 24% Buy | ||
Previous Opinion | 56% Buy | 24% Buy | 24% Buy | ||
Last Month's Opinion | 72% Sell | 8% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +3.11% since 06/25/24 | +2.52% since 06/25/24 | -3.56% since 06/25/24 | ||
Low | 236.50 on 06/26/24 | 220.02 on 06/26/24 | 428.76 on 06/28/24 | ||
High | 252.87 on 06/27/24 | 236.81 on 07/01/24 | 456.68 on 06/26/24 | ||
1-Month | |||||
%Chg | +66.82% since 05/31/24 | +1.72% since 05/31/24 | +17.38% since 05/31/24 | ||
Low | 147.25 on 06/07/24 | 220.02 on 06/26/24 | 368.57 on 06/10/24 | ||
High | 252.87 on 06/27/24 | 237.54 on 06/05/24 | 456.68 on 06/26/24 | ||
3-Month | |||||
%Chg | +63.94% since 04/02/24 | +10.20% since 04/02/24 | +9.66% since 04/02/24 | ||
Low | 141.98 on 04/25/24 | 189.44 on 04/19/24 | 352.77 on 05/14/24 | ||
High | 252.87 on 06/27/24 | 237.54 on 06/05/24 | 456.68 on 06/26/24 | ||
6-Month | |||||
%Chg | +27.03% since 01/02/24 | -14.53% since 01/02/24 | +14.30% since 01/02/24 | ||
Low | 141.98 on 04/25/24 | 189.44 on 04/19/24 | 349.86 on 03/20/24 | ||
High | 252.87 on 06/27/24 | 268.30 on 01/03/24 | 456.68 on 06/26/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 31,320,682 | 33,315,508 | 25,881,600 | ||
Shares Outstanding, K | 126,492 | 145,597 | 59,431 | ||
Annual Sales | 1,828,290,000 | 9,835,600,000 | 1,268,590,000 | ||
Annual Net Income | -440,240,000 | 1,161,100,000 | -295,050,000 | ||
Last Quarter Sales | 494,330,000 | 2,290,500,000 | 412,510,000 | ||
Last Quarter Net Income | -65,940,000 | 393,400,000 | -61,600,000 | ||
60-Month Beta | 0.37 | -0.04 | 0.64 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.16 on 05/02/24 | 3.67 on 04/24/24 | -1.04 on 05/09/24 | ||
Latest Earnings Date | 08/01/24 | 08/01/24 | 07/25/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 15.45 | 0.00 |